
Breaking Ground: New Insights on Down Syndrome and Alzheimer’s in Episode 140
2025-05-02
Author: Liam
Unlocking Potential: Episode 140 of Mind Moments Podcast Is Here!
Get ready for insightful discussions in the latest episode of the NeurologyLive® Mind Moments® podcast! This time, we dive deep into a groundbreaking topic: the intersection of Down syndrome and Alzheimer’s disease.
Expert Insights: A Conversation with Dr. Elizabeth Head
In this must-listen episode titled "Down Syndrome and Alzheimer’s: Clinical Trials, Equity, and Patient-Centered Progress," Dr. Elizabeth Head, a leading expert from UC Irvine, shares the latest updates from the Alzheimer Biomarker Consortium – Down Syndrome (ABC-DS). She unveils how research is evolving to include individuals with Down syndrome, a group that has traditionally been sidelined in clinical trials.
Progressing Together: Tackling Challenges in Research and Care
Dr. Head discusses the refined assessments tailored to the unique cognitive needs of those with Down syndrome. She also sheds light on the pressing challenges of distinguishing the symptoms of developmental delays from early signs of dementia, a crucial step in ensuring proper care and intervention.
Game-Changing Treatments and the Importance of Equity
With a focus on groundbreaking therapies, including the role of anti-amyloid treatments, Dr. Head emphasizes the need for equitable research participation. She advocates for improved clinician education and highlights the priorities of patients and families—such as maintaining independence and respect.
What’s New in Neurology?
In this week's Neurology News Minute, catch up on important updates, including new amendments to the GENERATION HD2 Trial for Huntington’s disease, FDA approvals for innovative epilepsy treatments, and much more.
Episode Breakdown: Key Highlights You Can't Miss
Here’s a sneak peek of the episode contents: - ABC-DS initiative overview and inclusion in Alzheimer’s research - Current progress in clinical trials for Down syndrome - Challenges in identifying dementia signs in Down syndrome populations - Access to specialized care - Eligibility for anti-amyloid therapies - Addressing research gaps and the need for inclusivity in healthcare.
Don’t Miss Out!
Subscribe to the Mind Moments podcast and make sure to leave a review! Tune in today and be part of a conversation that’s shaping the future of neurology.